Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy in an early brain metastasis model

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy in an early brain metastasis model

<p>Brain metastases develop frequently in patients with breast cancer, and present a pressing therapeutic challenge. Expression of vascular cell adhesion molecule 1 (VCAM-1) is upregulated on brain endothelial cells during the early stages of metastasis and provides a target for the detection...

Full description

Bibliographic Details
Main Authors:	Falzone, N, Ackerman, N, de la Fuente Rosales, L, Bernal, M, Liu, X, Peeters, S, Sarmiento Soto, M, Corroyer-Dulmont, A, Bernaudin, M, Grimoin, E, Touzani, O, Sibson, N, Vallis, K
Format:	Journal article
Published:	Ivyspring International Publisher 2018

Similar Items

Radionuclide spatial distribution and dose deposition for in vitro assessments of 212Pb‐αVCAM‐1 targeted alpha therapy
by: Frelin‐Labalme, A, et al.
Published: (2019)

Monte Carlo evaluation of radionuclides for early brain metastases targeting
by: Falzone, N, et al.
Published: (2018)

MRI imaging for sensitive tumour cell-tracking during development of early brain metastasis in a preclinical model
by: Corroyer-Dulmont, A, et al.
Published: (2017)

Development of an early brain metastasis geometric model for Geant4-DNA simulation
by: Falzone, N, et al.
Published: (2016)

VCAM-1 targeted alpha-particle therapy for early brain metastases
by: Corroyer-Dulmont, A, et al.
Published: (2019)

Subcellular targeting of theranostic radionuclides
by: Bavelaar, B, et al.
Published: (2018)

Targeted radionuclide therapy in combined-modality regimens
by: Gill, M, et al.
Published: (2017)

Subcellular Targeting of Theranostic Radionuclides
by: Bas M. Bavelaar, et al.
Published: (2018-09-01)

Targeted radionuclide therapy: new advances for improvement of patient management and response
by: Malcolm, J, et al.
Published: (2019)

Combining external beam radiation and radionuclide therapies: rationale, radiobiology, results, and roadblocks
by: Abbott, E, et al.
Published: (2021)

Targeting micrometastases: The effect of heterogeneous radionuclide distribution on tumor control probability
by: Falzone, N, et al.
Published: (2018)

Single cell S-value calculations of a stochastic cascade model for Auger-electron emitting radionuclides
by: Vallis, K, et al.
Published: (2016)

Methodological approach to development of dosimetric models of the human skeleton for beta-emitting radionuclides
by: M. O. Degteva, et al.
Published: (2019-06-01)

Targeting the nucleus: an overview of Auger-electron radionuclide therapy.
by: Cornelissen, B, et al.
Published: (2010)

Radionuclide imaging of angiogenesis
by: Patel, N
Published: (2013)

Determination of Optimum Imaging Numbers for 177Lu-PSMA Radionuclide Treatment Dosimetric Calculation
by: Bilal Kovan
Published: (2024-05-01)

Absorbed dose evaluation of auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values
by: Falzone, N, et al.
Published: (2017)

Photoresists as a high spatial resolution autoradiography substrate for quantitative mapping of intra- and sub-cellular distribution of Auger electron emitting radionuclides.
by: Falzone, N, et al.
Published: (2012)

Software for radionuclide vertebroplasty
by: A.V. Levchenko, et al.
Published: (2015-09-01)

Targeted Radionuclide Therapy Activates Prodrugs for Treating Metastasis
by: Zhibin Guo, et al.
Published: (2024-12-01)

Radionuclides in the environment

Radionuclides production/
by: Helus, Frank
Published: (1983)

Targeted alpha therapy with 212Pb or 225Ac: Change in RBE from daughter migration
by: Ackerman, N, et al.
Published: (2018)

Environmental Radionuclides in Surface Soils of Vietnam
by: P.D. Hien, et al.
Published: (2002-01-01)

Engineered mineralogical interfaces as radionuclide repositories
by: G. B. Douglas, et al.
Published: (2023-02-01)

The Role of Radionuclide Diagnostic Methods in Neuro-Oncology
by: T. Yu. Skvortsova, et al.
Published: (2020-09-01)

Emerging theragnostic radionuclide applications for hepatocellular carcinoma
by: N. E. Nyakale, et al.
Published: (2023-10-01)

Radioimmunotherapy for brain metastases: The potential for inflammation as a target of choice
by: Corroyer-Dulmont, A, et al.
Published: (2021)

Standardization of radionuclides : proceedings
by: Symposium on Standardization of Radionuclides (1966: Vienna)
Published: (1967)

Radionuclide imaging techniques /
by: Dendy, P. P., et al.
Published: (1985)

Radiation spectra of radionuclides/
by: 429124 Metcalfe, T. B.
Published: (1976)

Radionuclide teranostic of malignancies
by: V. I. Chernov, et al.
Published: (2016-11-01)

Development of radionuclide calorimeter
by: LIU Lifei, et al.
Published: (2022-02-01)

Radionuclide concentrations in food and the environment /
by: Poschl, Michael, et al.
Published: (2007)

Radionuclide synovectomy – essentials for rheumatologists
by: Marek M. Chojnowski, et al.
Published: (2016-07-01)

Optimization of planning radionuclide diagnostic tests in osteoscintigraphy
by: N. A. Maksimova, et al.
Published: (2021-03-01)

Targeted opening of the blood-brain barrier using VCAM-1 functionalised microbubbles and “whole brain” ultrasound
by: Johanssen, V, et al.
Published: (2024)

RADIONUCLIDE QUANTITATIVE IN ASSESSMENT OF MYOCARDIAL BLOOD FLOW
by: N. G. Krivonogov, et al.
Published: (2013-06-01)

RADIATION-HYGIENIC JUSTIFICATION OF OUTPATIENT RADIONUCLIDE THERAPY
by: B. Ja. Narkevich, et al.
Published: (2015-08-01)

Dosimetric Evaluation of <sup>177</sup>Lu Peptide Receptor Radionuclide Therapy Using GATE and Planet Dose
by: Ioanna Stamouli, et al.
Published: (2023-08-01)